Find a Top Oncologist Near Me – Book an Appointment Instantly

Dr. Singavi’s clinical interests include solid tumors and hematologic disorders (both malignant and non-malignant – thrombotic/bleeding disorders/etc.). His special interests include Neuro-oncology, Breast Oncology, and Genitourinary.

When not working, Dr. Singavi enjoys spending time with his family, traveling, and watching sports.

Patient Reviews:

"My father has been a patient of Dr Singavi for 3 years. Dr Singavi is an absolute gem! He is compassionate and very knowledgeable. He takes his time to listen to patient concerns and help the patient/family understand the treatment plan. I can’t say enough how grateful I am my father is in his care. It’s so rare to find a doctor that is both skilled in his field and has top notch bed side manor. Dr Singavi is both!!" -Laura

"Dr. Singavi is the most amazing Dr. He is kind, compassionate, and takes all the time in the world to make sure you understand your condition, and your treatment plan. His entire office staff is also very compassionate and carring. If you have to see an Oncologist, and let's face it, nobody wants to, Dr. Singavi and his staff are the people you want to be with during your care." -Sandy

Kamlesh Kumar Sankhala MD (also known as Dr. Kumar by his patients and colleagues) is a Medical Oncologist at Cedars-Sinai Medical Center in Los Angeles, California, and Director of Precision NextGen Oncology and Research Center, an independent center focused on treatment of complex, rare cancer and Sarcomas, as well as, clinical research in Oncology for expedited drug development and clinical research. Precision NextGen Oncology and Research Center  focuses on care for patients with Advanced Cancers who are refractory to conventional treatments. We provide care to these patients with multi- institutional coordinated care and access to novel and next generation therapies with or without clinical trials.

Dr. Sankhala specializes in clinical research and has pioneered a niche in treatments for patients with advanced and complex malignancies refractory to conventional treatments, along with rare cancer such as sarcomas.

Dr. Sankhala received his medical degree at the University of Rajasthan, India and undertook his internal medicine residency and fellowship training in oncology at the University of Texas Health Science Center. He had two years of additional fellowship in Oncology Drug Development at the University of Texas’s Institute for Drug Development. He was a clinical faculty at the University of Texas’s Health Science Center, and Clinical Investigator at the Institute for Drug Development (IDD). He also served as team leader for the University’s Sarcoma Program. Dr. Sankhala has served as the Co-Director, Sarcoma Medical Oncology and the Director of Clinical Research and Experimental Therapeutics Cedars-Sinai Medical Center’s THO.

Besides his Medical Oncology practice in advanced refractory cancers, Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspects of these agents. With an esteemed background in novel drug research and phase-1 clinical trials, Dr. Sankhala has evolved into a physician devoted to the translational research of novel anti-cancer agents by applying himself to the study and evaluation of pre-clinical and clinical implications of new agents in patients with advanced cancers. He has developed a clinical proficiency in using novel anticancer drugs for patients with advanced malignancies and has optimized existing chemotherapeutic agents by reducing toxicities and increasing efficacy, thereby yielding better responses to anti-cancer therapies. Dr. Sankhala's extensive clinical research background includes serving as the principal investigator and sub-investigator in more than 250 Phase-1 and other Oncology clinical trials.

Dr. Sankhala has served on advisory boards for many pharmaceutical companies to design, implicate, and conduct research on many novel oncology therapeutic molecules and has also helped several other companies to optimize and find the marketplace for novel therapies. He has also served as a member of Protocol Review and Management Committee (PRMC) and institutional review board (IRB) at Samuel Oschin Cancer Center at Cedars-Sinai Cancer Institute in Los Angeles.

Dr. Sankhala has been a reviewer of reputed journals in the field of Oncology such as the British Journal of Cancer, Cancer Chemotherapy & Pharmacology, Journal of Medical Case Report, Onkologie, and Bone Marrow Transplantation. He is an editorial board member for the Journal of Cancer Science, and Therapy and Chemotherapy.

Dr. Sankhala’s has authored and co-authored 71 numerous articles, and abstracts in journals including Journal of Clinical Oncology, Clinical Cancer Research, Oncology immunology, Investigational New Drugs, Cancer Journal, Expert Review in Hematology, Cancer chemotherapy and Pharmacology, JAMA Oncology, Clinical Breast Cancer, Cancer Chemotherapy Pharmacology, Molecular Cancer Therapeutics, Leukemia Lymphoma, Current Drug Target, Expert Opinion in Investigational Drugs, Future Oncology, Target Oncology, Expert opinion in Drug Metabolism and Toxicology, and Clinical Advancement in Hematology Oncology.

He is the recipient of the American Society of Clinical Oncology Foundation’s Merit Award and the AACR- NCI scholarship for Molecular Biology in Clinical Oncology. 

He has presented in many major national and international meetings including the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), Japan’s Sarcoma Society, and many others. 

Beside Cedars-Sinai Medical Center, Dr. Sankhala has affiliations with various esteemed health facilities across Los Angeles, including Univversity of California at Los Angeles, University of Southern California and Providence Saint John's Health Center.

Dr. Sankhala’s academic interests extend to progressive fields including Healthcare Utilization Management, Managed Care, Consumer-Directed Healthcare, Healthcare Economics, and Medical Oncology Trend Management.

Founder & Medical Director
Angelique E Richardson MD PhD | The Center for Phenomenal Health & Wellness Inc.
San Diego, California

Angelique E. Richardson, MD, PhD, is a board-certified medical oncologist, physician-scientist, and nationally recognized leader in breast cancer care, cancer health equity, and women’s health across the lifespan. She is the Founder and Medical Director of The Center for Phenomenal Health & Wellness, a concierge women’s health practice in San Diego dedicated to menopause, perimenopause, cancer survivorship, and long-term wellness for women.

Dr. Richardson brings together academic rigor, clinical excellence, and deeply personalized care, offering women a level of expertise typically found at major academic cancer centers—delivered in a thoughtful, relationship-centered private practice setting.

Prior to founding her private practice, Dr. Richardson served as an Associate Professor of Medicine at the University of California, San Diego (UCSD) within the Comprehensive Breast Health Center. There, she specialized in the diagnosis and treatment of breast cancer while leading and contributing to clinical trials, translational research, and community-engaged cancer equity initiatives.

She has served as Principal Investigator on multiple national and industry-sponsored clinical trials, including Phase I–III breast cancer studies, and has been actively involved in advancing access to clinical trials for historically underserved populations.

Dr. Richardson is a physician-scientist with dual MD and PhD training, holding a doctorate in Microbiology and Molecular Genetics with an emphasis in cancer biology. Her research has focused on:

• Breast cancer biology and signaling pathways

• Cancer health disparities and survival inequities

• Biomarkers in breast cancer prognosis and treatment response

• Implementation of patient-reported outcomes in underserved populations

She has authored peer-reviewed publications, contributed to textbook chapters, and presented her work nationally and internationally through organizations such as AACR, ASCO, SABCS, and NIH-affiliated forums.

Her work and leadership have been recognized through numerous honors, including:

• Robert A. Winn Diversity in Clinical Trials Leadership Award

• Merck Investigator Studies Program (MISP) funding

• Early Stage Investigator Awards

• National leadership roles in cancer equity and survivorship initiatives

In addition to her oncology expertise, Dr. Richardson is deeply committed to women’s health beyond cancer treatment. She specializes in helping women navigate:

• Perimenopause and menopause

• Hormonal and non-hormonal symptom management

• Long-term survivorship and quality-of-life optimization

• Wellness strategies for women at high risk for breast cancer

• Care planning for women who are not candidates for standard hormone therapy

Her approach is evidence-based, individualized, and deeply informed by her years caring for breast cancer survivors, making her uniquely positioned to guide women through complex hormonal transitions safely and thoughtfully.

Dr. Richardson earned her Doctor of Medicine (MD) and PhD from Loma Linda University, where her doctoral research examined molecular drivers of aggressive breast cancer biology. She completed:

• Internal Medicine Residency at White Memorial Medical Center (Los Angeles)

• Hematology/Oncology Fellowship at Penn State College of Medicine

• Advanced Clinical Breast Oncology training at the University of Miami

Dr. Richardson serves on numerous local, state, and national advisory boards, including:

• Susan G. Komen National Advisory Board and Leadership Council

• California Breast Cancer Research Council (University of California)

• American Society of Clinical Oncology (ASCO)

• American College of Physicians (ACP)

• National Medical Association (NMA)

She is a frequent invited speaker for professional conferences, community organizations, and national educational forums, and remains deeply engaged in mentorship, advocacy, and community outreach.

Dr. Richardson believes that women deserve time, expertise, and care that honors the whole person—not just a diagnosis. Her practice model is intentionally designed to provide:

• Longer visits

• Direct physician access

• Thoughtful, personalized care plans

• Preventive, survivorship-focused medicine

Dr. Michele Sazama is a board-certified adult nurse practitioner with extensive clinical experience, including over twenty years working with oncology patients.  She holds national specialty certifications as an Advanced Oncology Certified Nurse Practitioner (AOCNP) and Board-Certified Medical Affairs Specialist (BCMAS). 

Dr. Sazama was an instructor for Johns Hopkins University School of Nursing for many years and continues to serve as adjunct faculty for the Arizona State University nursing program.  She created and directed a formal clinical rotation in oncology for graduate and doctoral nursing candidates, helping Arizona students develop their ability to safely care for oncology patients.

Dr. Sazama practices evidence-based medicine with a holistic focus and respect for individual choice.

Her clinical interests include psychoneuroimmunology, stress response, coping mechanisms, biofeedback, culturally diverse healing modalities, metaphysical science, meditation, and neuroplasticity.

Specializing in treating benign and malignant breast disease, Dr. Cox has a special interest in breast conservation and minimally-invasive techniques. With this emphasis, she helps each patient choose the best surgical and oncologic results while preserving as much normal breast tissue as possible.

After completing undergraduate and graduate degrees at California State University, Dr. Cox graduated from Flinders University of South Australia. She completed her general surgery training at Pennsylvania State University's Milton S. Hershey Medical Center and a Breast Surgical Oncology fellowship at The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Hospital.

In her spare time, Dr. Cox enjoys Bikram yoga and hiking in the Arizona foothills with her two shiba inus. She travels and, in particular, enjoys the beautiful cultures and histories of the Asian continent.

Patient Reviews: 

"Dr. Cox is a fantastic Dr./surgeon. I went to her after receiving positive cancer biopsy results. That in and of itself is super scary, let alone not knowing what was going to happen next. This wonderful, warm Dr. sat next to me and explained everything so I could understand it. Dr Cox took her time with me, she drew pictures to show me everything that was going on and what she was going to do. Dr. Cox tells you how it is in the most compassionate way. I felt very cared for. I had a lumpectomy with sentinel node biopsy. She did a beautiful job surgically. The follow up phone calls were made in a timely manner. Her staff is wonderful as well. I highly recommend Dr. Cox and going forward should I do mastectomy she will be my surgeon hands down!" -Deborah

"I took my wife to our 1st consultation. The experience was very informative. Dr Cox spent the time to go through all our options. She was so personable and kind I left her office with my wife feeling we have made the best choice in the valley. Looking forward to our journey with her on our team. I highly recommend her." -Pete

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Dr. Benjamin Ball grew up in a smaller town within the New York Tri-State area. As a young adult, he moved to Charlottesville, Virginia where he completed a double major in chemistry and biology at the University of Virginia, graduating with high honors. He remained at UVA for medical school, where his pre-clerkship GPA was top five in his class. He then completed his neurosurgical residency at the University of California, Irvine, where he spent a year completing an enfolded skull-base surgery fellowship. His surgical interests include tumors, spine, and trauma. In his free time, he enjoys watching movies, reading science fiction books, attending local comedy shows, and watching UVA Men’s Basketball dominate.